DxLab Inc. (DxLab) is a biotech startup, spun out of MIT and Harvard in September 2020, developing and commercializing a next-generation point-of-care (POC) diagnostic solution for rapid, on-site detection of dangerous pathogens. Combining proprietary platform technology with novel target detection and signal processing methods, we are advancing a pipeline of rapid POC tests.
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
The MIT Legatum Center annual conference serves as a platform where innovation-driven entrepreneurs, corporates, investors, academics, policymakers, and fellows come together to discuss pressing challenges in global growth markets.